InvestorsHub Logo
Followers 145
Posts 27565
Boards Moderated 3
Alias Born 02/07/2004

Re: None

Monday, 02/01/2016 11:22:35 AM

Monday, February 01, 2016 11:22:35 AM

Post# of 651
BiondVax Pharma (BVXV) Given “Buy” Rating at Aegis
Posted by Deane Yates on Feb 1st, 2016


BiondVax Pharma logoBiondVax Pharma (NASDAQ:BVXV)‘s stock had its “buy” rating reaffirmed by Aegis in a report issued on Tuesday, Analyst Ratings Net reports.
Shares of BiondVax Pharma (NASDAQ:BVXV) opened at 3.60 on Tuesday. BiondVax Pharma has a 12 month low of $3.28 and a 12 month high of $5.78. The stock’s 50 day moving average is $3.74 and its 200 day moving average is $3.89. The firm’s market capitalization is $12.16 million.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BVXV News